Stock 660 WAI CHUN BIO-TECHNOLOGY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Wai Chun Bio-Technology Limited

Equities

660

KYG9450C1107

Delayed Hong Kong S.E.
Other stock markets
 09:08:08 27/06/2024 BST 		5-day change 1st Jan Change
0.125 HKD 0.00% Intraday chart for Wai Chun Bio-Technology Limited 0.00% -13.19%
05-31 Wai Chun Bio-Technology Limited Announces Appointment of Fenn David as the Company Secretary, Effective June 1 ,2024 CI
05-21 Wai Chun Bio-Technology Limited Announces Resignation of Lam Kai Kei as Company Secretary and Authorised Representative CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Wai Chun Bio-Technology Limited Announces Appointment of Fenn David as the Company Secretary, Effective June 1 ,2024
CI
Wai Chun Bio-Technology Limited Announces Resignation of Lam Kai Kei as Company Secretary and Authorised Representative
CI
Wai Chun Bio-Technology Limited Announces Change of Independent Non-Executive Director
CI
Wai Chun Bio-Technology Limited Announces Company Secretary Changes
CI
Wai Chun Bio-Technology's Fiscal H1 Attributable Loss Narrows
MT
Wai Chun Bio-Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2023
CI
Wai Chun Bio-Technology Limited Announces Change of Company Secretary and Authorised Representative
CI
Winding-Up Petition Against Wai Chun Bio-Technology Withdrawn
MT
Wai Chun Bio-Technology Names Controlling Shareholder's Son as Chairman/CEO
MT
Wai Chun Bio-Technology Limited Announces Appointment of Lam Ka Chun as Chief Executive Officer
CI
Wai Chun Bio-Technology Limited Announces Appointment of Lam Ka Chun as Chairman of the Board
CI
Wai Chun Bio-Technology Incurs Loss in Fiscal Year 2023
MT
Wai Chun Bio-Technology Limited Reports Earnings Results for the Full Year Ended June 30, 2023
CI
Wai Chun Bio-Technology Limited Announces Board Changes
CI
Wai Chun Bio-Technology Limited Announces Change of Company Secretary and Authorised Representative
CI
Wai Chun Bio-Technology Limited Announces Change of Head Office and Principal Place of Business in Hong Kong
CI
Wai Chun Bio-Technology Limited Announces Management Changes
CI
Wai Chun Bio-Technology's H2 2022 Loss Widens
MT
Wai Chun Bio-Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2022
CI
Wai Chun Bio-Technology Limited Announces Executive Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 660 Stock
  4. News Wai Chun Bio-Technology Limited